securities fraud

1946 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Immutep Stock Plummets 82.6% on Failed Clinical Trial; Class Action Probe Launched

Immutep's $IMMP stock crashed 82.6% after discontinuing Phase III trial for lead drug candidate. Rosen Law Firm investigating potential securities violations and class action claims.
IMMPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Eos Energy Faces Class Action Over Scaling Claims as Stock Crashes 39%

Eos Energy ($EOSE) faces securities lawsuit over false scaling statements and undisclosed manufacturing problems. Stock plunged 39% after missing revenue targets.
EOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Navan Stock Craters 63% as Securities Lawsuit Claims IPO Disclosure Failures

Navan stock plummeted 63% from $25 IPO price after lawsuit alleges material omissions regarding $95M S&M expense spike.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

GSI Technology Stock Plummets 14% on AI Chip Capability Allegations

GSI Technology faces securities investigation after allegations of misleading statements about AI chip capabilities. Stock fell 14.2% following February disclosure.
GSITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Apollo Global Hit by $12B Market Wipeout Over Epstein Disclosure Scandal

Apollo Global Management faces securities lawsuit alleging executives misrepresented Epstein business dealings. Stock fell 15% as $12B in market value evaporated.
APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Coty Faces Major Securities Lawsuit Over Misled Investors on Q1 Earnings Claims

Coty Inc. ($COTY) faces class action lawsuit alleging false statements about business trends. Company revealed severe operational deterioration months after November 2025 earnings guidance.
COTYsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Lowey Dannenberg, P.C.

ADMA Biologics Under SEC Investigation for Alleged Channel Stuffing Scheme

ADMA Biologics faces SEC investigation for allegedly inflating 2025 revenue growth from -3% actual to +20% reported through channel stuffing practices with distributors.
ADMAsecurities fraudinvestor losses
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

Camping World Faces Securities Fraud Lawsuit Over Inventory Claims

Law firm sues Camping World Holdings for allegedly overstating inventory management capabilities and consumer demand between April 2025 and February 2026.
CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

PicPay Faces Securities Probe Over Credit Loss Disclosure, Shareholder Recovery Effort Launched

Johnson Fistel investigates PicPay over BRL 88 million undisclosed credit loss increase, seeking shareholders to recover losses from resulting stock decline.
PICSsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Bleichmar Fonti & Auld Llp

Simply Good Foods Faces Securities Probe Over OWYN Expansion Failures

$SMPL faces securities fraud investigation over failed OWYN expansion, triggering 18% stock drop and $249M impairment charge amid weak Q2 results.
SMPLsecurities fraudclass action lawsuit
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

PSIX Shareholders Seek Lead Plaintiff in Data Center Power Systems Fraud Case

Power Solutions International investors can join securities fraud lawsuit alleging company misrepresented sales prospects and costs between May 2025 and March 2026.
PSIXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

PomDoctor Hit With Class Action Over Alleged Stock Manipulation Scheme

Class action filed against $POM alleging false statements, fraudulent social media promotion, insider share dumping via offshore accounts, and artificial trading activity during Oct-Dec 2025.
POMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Stellantis Faces Class Action Over $24B Reset, Stock Plummets 23%

Portnoy Law Firm files class action against Stellantis for alleged misstatements on electrification prospects. Stock crashed 23% after €22.2B reset announcement.
STLAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

SMCI Faces Class Action Over China Export Control Violations and Compliance Failures

Super Micro Computer faces securities fraud class action over alleged false statements regarding China sales violating U.S. export controls and inadequate compliance practices.
SMCIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Aldeyra Therapeutics Faces Class Action Over Reproxalap Drug Claims

Schall Law Firm mobilizes class action against Aldeyra Therapeutics for alleged securities fraud tied to reproxalap drug claims. Eligible investors must participate by May 29, 2026.
ALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Pinterest Faces Securities Fraud Lawsuit Over Ad Revenue, Tariff Disclosures

Class action lawsuit filed against Pinterest for allegedly making false statements about advertising revenue and tariff impacts on business between February 2025 and February 2026.
PINSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

$PINS Faces Class Action Over Undisclosed Revenue Headwinds, Tariff Guidance

Pinterest faces class action lawsuit alleging failure to disclose revenue declines and tariff impacts. Stock fell 16.83% after weak Q1 2026 guidance.
PINSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Super Micro Computer Faces Class Action Over Hidden China Sales and Export Violations

Class action lawsuit filed against $SMCI alleging undisclosed Chinese sales violating export controls and concealed compliance weaknesses. Lead plaintiff deadline set for May 26, 2026.
SMCIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Corcept Therapeutics Faces Class Action Over Relacorilant Clinical Trial Claims

Class action filed against $CORP alleging securities fraud over misleading statements about relacorilant clinical trials and FDA regulatory prospects.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Book-to-Bill Ratio

Class action lawsuit filed against $MDPC alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026, claiming overstated business prospects.
MEDPsecurities fraudclass action lawsuit